Our newest onevoice community, oneSMAvoice empowers people impacted by spinal muscular atrophy.
Our web and mobile experiences unify rare disease populations around resources and community conversation. Key features include:
Customized rare disease medical publication programs that address the intricacies of publication planning in rare disease.
Our approach to scientific communications celebrates that rare patients, advocates, and caregivers are critical shapers of their rare disease ecosystem.
Our newest onevoice community, oneSMAvoice empowers people impacted by spinal muscular atrophy.
What does it take to build a sustainable patient community? This white paper outlines rareLife’s three-step, rare-focused approach.
In partnership with the Sickle Cell Disease Association of America, oneSCDvoice empowers people impacted by sickle cell disease.
The “Morquio Syndrome: A Guide to Understanding MPS IV” booklet was designed and executed to support the information needs of people diagnosed with MPS IV and those who support their care.
How many zebras are there, and where are they hiding in medical literature? A literature review of publications on rare diseases.
Developed in partnership with Cancer Prevention Pharmaceuticals, oneFAPvoice is the first community that rareLife solutions created.
‘Negative’ clinical trials in rare diseases and beyond: reclassification and potential solutions
The National MPS Society Physician MasterClass was designed and executed to inspire up-and-coming medical geneticists.
In partnership with Amyloidosis Support Groups, oneAMYLOIDOSISvoice empowers people impacted by amyloidosis.
In partnership with the Graves’ Disease and Thyroid Foundation, oneGRAVESvoice empowers people impacted by Graves’ disease and thyroid eye disease.
In partnership with Ultragenyx Pharmaceutical, oneXLHvoice empowers people impacted by X-linked hypophosphatemia.
Our proprietary Clinical Trial Finder, featured on selected onevoice sites, helps patients and caregivers find clinical trials based on tailored search criteria.
I met rareLife solutions in their early startup stage; I was hooked from the start as they described their vision for “smarter rare disease drug development and commercialization” anchored by a technology solution intended to build community called onevoice. As a small rare disease company in the clinical development stage, we understand the power of the patient and caregiver community, so we felt the rareLife philosophy had hit the nail on the head. This could be disruptive, just like our potential drug in Phase 3 trials for familial adenomatous polyposis. So we were fortunate to be their flagship program, which is called FAPvoice. It went from nothing to hundreds of patients (in a very small rare disease) in a very short time. We immediately saw a positive impact on our relationship with the FAP community, our ability to query patients and KOLs, and even an unintended positive impact on our Phase 3 trial enrollment (word gets around on the grapevine). We continue to be inspired by rareLife’s commitment and dedication to their (and our) mission ever since.
This site amplifies the best of existing resources found across the internet – that can be mutually beneficial to content sites, particularly when a community is connected.
It is important to have such a forum that provides high quality information AND interacts with patients.
It’s an absolute pleasure to work with you guys. We’re so glad we found you. Honestly, forgive me the pun, it’s rare to find people this knowledgeable, this engaged, and this good.
In each of the projects that I’ve been working, I have felt that I’ve been working with a very professional and accomplished group of people. In every exchange – be it email or in the meetings, they have been a pleasure to work with. It’s clear that they are also experienced in what they are doing and that made our work much more efficient to develop the outputs.
I’m impressed with the quantity of information and the range of topics covered. Without a platform like oneSCDvoice, it would take hours to find this kind of information on sickle cell disease and trait – and then hours more to determine which sources are reliable and trustworthy.
First of all, congratulations on an excellent manuscript. It’s so difficult to pull together disparate comments from umpteen individuals but you have done a great job. Consider this as my formal approval for publication.
Hello, I am a new member of this website which I stumbled upon by accident today when I was doing my weekly search. I think that this splendid website is a great idea and it feels amazing to be part of such a community.
Our video has been well received. You and your team are superstars ????.
It seems like it’s more of a close-knit community, which I was surprised about. The [Facebook] groups are pretty big and I can get lost in it. I don’t feel like that in …
I’ve never seen anything like this, and I’ve been in the industry a long time.
Very excited to be a part of this and excited about the amount of information and the ‘holistic approach’ of including all types of sources and credible information … this will be very helpful to the patients.
Founder & CEO
Dan’s experiences and observations have led him to believe that there is a better, smarter way to engage all rare disease stakeholders and accelerate disease understanding and treatment success. He believes the power of collaboration is the linchpin to this fundamental change.
President, rareLife solutions
Laura is a strategic thinker who leads the SciComm team to surpass client expectations. As the proud mom of a teenage daughter with a rare disease, Laura spends a lot of time picking up towels from the bathroom floor, just like most moms. When not working (or picking up towels) you may find Laura riding dressage, hiking, practicing yoga, or trying to finish that darn MBA.
Sr. Director, Client Solutions
Patti is Senior Director of Client Solutions for scientific communications and medical publications. She found her niche in Sci Comm because of its fast pace, challenging content, and demand for excellence. At rareLife, she finds that focusing on rare diseases and the hope for cures adds layers of meaning and motivation. When not at her desk, you’ll find Patti baking while listening to NPR, walking the shore with pups Tuxy and Jersey Girl, or planning the next “Family Fun Night” dance party with her husband, family, and friends.
Sr. Director, Product Management
Rob is a digital leader specializing in product management, user experience strategy, and new product development. In his spare time, he is active in the Washington, DC, design community, runs trail ultramarathons, and builds structures out of cardboard with his 7-year-old daughter.
Sr. Director, Technology
Justin is a technology leader with 25 years of experience in software development methodologies and technologies. His areas of expertise include large-scale, high-traffic applications built with the latest cloud-based toolsets. He also is the team’s resident expert on all things Star Wars, Pokemon, and The Grateful Dead.
Vice President, Medical and Scientific Affairs
Mukund is Vice President of Medical and Scientific Affairs and principal medical writer. He holds a PhD in molecular biology, an MBA, and an ISMPP CMPP credential. His past work includes pharmaceutical industry drug discovery and medical communications. He is on the editorial board for 2 rare disease journals, is a Rotarian, has lived on 4 continents, loves to cook, and is the recipient of a Presidential Volunteer Service Award.
Michele is a Medical Writer with the rareLife team. When she became a rareMom, she left professional music to earn a PhD in Pharmacology from Yale University. Along with experience in the biotech industry, she also enjoys making commercial and music videos.
Aparna obtained a PhD in Pharmaceutics and holds CMPP and Lean Six Sigma Green Belt certifications. She has more than 5 years of experience in the medical writing industry with a focus on strategic publication planning and scientific communications using eLearning platforms. At rareLife, Aparna hopes to contribute to making scientific communications in the rare disease space more accessible to all stakeholders. In her free time, she enjoys reading and binge-watching teenage shows with her preteen daughter.
Sonali is a medical writer with the rareLife team. She earned a PhD in medical parasitology. During her PhD, she developed an interest in reading and writing about patients’ health issues. Her past experience includes academic and scientific writing. She is the proud mom of an adorable baby. When not working, she enjoys spending time with him.
Client Solutions Director
E.J. is a Client Solutions Director and communications specialist with more than 20 years’ experience in the scientific communications and healthcare information technology spaces. He brings strong project management, communications, and relationship-building skills into the rare community, delivering projects on time and on budget. When not on the front lines of the rare disease effort, he is usually found on the sideline of a soccer field cheering on his teenagers, running, hiking, watching his beloved Manchester United and FC Barcelona, and enjoying trips with his wife and kids to our great national parks.
Chief Financial Officer
Nadeem is a recognized expert in the pharmaceutical services sector. He has a background with the big four in strategy, M&A, business development, financial planning, financial reporting, auditing, accounting, and tax.
Chief Technology Officer
Shahid is an award-winning government 2.0, health IT, and patient engagement/experience software expert and internationally recognized thought leader with over 25 years of technology strategy, software engineering, entrepreneurship, speaking, and writing experience.
Kagin is an innovative and driven accounting and FP&A professional with over 20 years of experience.